SynthesisFrontiers in endocrinology2026

Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies.

Jiazhong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.